1006 related articles for article (PubMed ID: 28387722)
1. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
2. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
Tronel C; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Dupont AC; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398245
[TBL] [Abstract][Full Text] [Related]
3. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
[TBL] [Abstract][Full Text] [Related]
4. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
[TBL] [Abstract][Full Text] [Related]
5. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO.
Narayanaswami V; Dahl K; Bernard-Gauthier V; Josephson L; Cumming P; Vasdev N
Mol Imaging; 2018; 17():1536012118792317. PubMed ID: 30203712
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
7. TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?
Largeau B; Dupont AC; Guilloteau D; Santiago-Ribeiro MJ; Arlicot N
Contrast Media Mol Imaging; 2017; 2017():6592139. PubMed ID: 29114179
[TBL] [Abstract][Full Text] [Related]
8. PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases.
Ghadery C; Best LA; Pavese N; Tai YF; Strafella AP
Curr Neurol Neurosci Rep; 2019 May; 19(7):38. PubMed ID: 31139952
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in Neurodegenerative Disorders-a Review.
Schain M; Kreisl WC
Curr Neurol Neurosci Rep; 2017 Mar; 17(3):25. PubMed ID: 28283959
[TBL] [Abstract][Full Text] [Related]
10. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography.
Dollé F; Luus C; Reynolds A; Kassiou M
Curr Med Chem; 2009; 16(22):2899-923. PubMed ID: 19689272
[TBL] [Abstract][Full Text] [Related]
11. TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.
Guilarte TR
Pharmacol Ther; 2019 Feb; 194():44-58. PubMed ID: 30189290
[TBL] [Abstract][Full Text] [Related]
12. The methodology of TSPO imaging with positron emission tomography.
Turkheimer FE; Rizzo G; Bloomfield PS; Howes O; Zanotti-Fregonara P; Bertoldo A; Veronese M
Biochem Soc Trans; 2015 Aug; 43(4):586-92. PubMed ID: 26551697
[TBL] [Abstract][Full Text] [Related]
13. Tracing the History of the Human Translocator Protein to Recent Neurodegenerative and Psychiatric Imaging.
Downer OM; Marcus REG; Zürcher NR; Hooker JM
ACS Chem Neurosci; 2020 Aug; 11(15):2192-2200. PubMed ID: 32662626
[TBL] [Abstract][Full Text] [Related]
14. Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
Vivash L; O'Brien TJ
J Nucl Med; 2016 Feb; 57(2):165-8. PubMed ID: 26697963
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
[TBL] [Abstract][Full Text] [Related]
16. Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia.
Kreisl WC; Henter ID; Innis RB
Adv Pharmacol; 2018; 82():163-185. PubMed ID: 29413519
[TBL] [Abstract][Full Text] [Related]
17. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
18. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.
Guilarte TR; Rodichkin AN; McGlothan JL; Acanda De La Rocha AM; Azzam DJ
Pharmacol Ther; 2022 Jun; 234():108048. PubMed ID: 34848203
[TBL] [Abstract][Full Text] [Related]
19. Imaging Neuroinflammation in Neurodegenerative Disorders.
Masdeu JC; Pascual B; Fujita M
J Nucl Med; 2022 Jun; 63(Suppl 1):45S-52S. PubMed ID: 35649654
[TBL] [Abstract][Full Text] [Related]
20. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands.
Owen DR; Matthews PM
Int Rev Neurobiol; 2011; 101():19-39. PubMed ID: 22050847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
